Serum levels of osteoprotegerin and receptor activator of nuclear factor kB ligand (RANKL) in children with various stages of chronic renal disease

被引：0
|
作者：
Siomou, E.
Challa, A. S.
Petropoulou, F.
Siapera, D.
Mitsioni, A.
Stefanidis, C. J.
机构：
[1] Univ Ioannina, Dept Child Hlth, GR-45110 Ioannina, Greece
[2] PA Kyriakou Childrens Hosp, Athens, Greece
来源：
BONE | 2007年 / 40卷 / 06期
关键词：
D O I：
10.1016/j.bone.2007.04.024
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [1] SERUM LEVELS OF OSTEOPROTEGERIN, RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KB LIGAND (RANKL) AND OTHER BIOCHEMICAL MARKERS OF BONE TURNOVER IN CHILDREN WITH CHRONIC KIDNEY DISEASE
    Siomou, E.
    Challa, A.
    Printza, N.
    Serbis, A.
    Petropoulou, F.
    Mitsioni, A.
    Papachristou, F.
    Stefanidis, C. J.
    [J]. PEDIATRIC NEPHROLOGY, 2009, 24 (09) : 1881 - 1882
  • [2] Serum levels of receptor activator of nuclear factor kB ligand (RANKL) in healthy women and men
    Kerschan-Schindl, K.
    Wendlova, J.
    Kudlacek, S.
    Gleiss, A.
    Woloszcuk, W.
    Pietschmann, P.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S340 - S340
  • [3] The serum concentration of the receptor activator of nuclear factor-kB ligand (RANKL), osteoprotegerin (OPG) and lipids profile in children with nephrotic syndrome
    Panczyk-Tomaszewska, M.
    Ziolkowska, H.
    Adamczuk, D.
    Gorska, E.
    Stelmaszczyk-Emmel, A.
    Roszkowska-Blaim, M.
    [J]. BONE, 2009, 45 : S86 - S86
  • [4] Serum osteoprotegerin and receptor activator nuclear factor ligand (RANKL) in Paget's disease of bone.
    Alvarez, L
    Guañabens, N
    Peris, P
    Ros, I
    Ferró, T
    Pons, F
    Filella, X
    Monegal, A
    Muñoz-Gomez, J
    Ballesta, AM
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S380 - S380
  • [5] Osteoprotegerin (OPG) and receptor activator of NF-kB ligand (RANKL) serum levels in patients on chronic hemodialysis.
    Gonnelli, S
    Montagnani, A
    Cepollaro, C
    Franci, M
    Lucani, B
    Gaggiotti, E
    Nuti, R
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S395 - S395
  • [6] Receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin levels in multiple sclerosis
    Kurban, Sevil
    Akpinar, Zehra
    Mehmetoglu, Idris
    [J]. MULTIPLE SCLEROSIS, 2008, 14 (03): : 431 - 432
  • [7] Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: Are they of any help?
    Wagner, Doris
    Fahrleitner-Pammer, Astrid
    [J]. WIENER MEDIZINISCHE WOCHENSCHRIFT, 2010, 160 (17-18) : 452 - 457
  • [8] Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: Are they of any help?Osteoprotegerin (OPG) und Receptor Activator for Nuclear Factor kappaB Ligand (RANKL) Bestimmung im Serum: Sinn oder Unsinn?
    Doris Wagner
    Astrid Fahrleitner-Pammer
    [J]. Wiener Medizinische Wochenschrift, 2010, 160 (17-18) : 452 - 457
  • [9] Osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) in the serum of healthy adults
    Jung, K
    Lein, M
    Von Hösslin, K
    Grosse, A
    Roth, S
    Possinger, K
    Lüftner, D
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (03): : 177 - 181
  • [10] SERUM RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KB LIGAND (RANKL) AS BIOMARKER OF CHRONIC HEART FAILURE IN ELDERLY MALES
    Bozic, B.
    Loncar, G.
    Prodanovic, N.
    Cvorovic, V.
    Radojicic, Z.
    Dimkovic, S.
    Popovic-Brkic, V.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 32 - 32
12345